We are live on ! Find out more
ZYME icon

Zymeworks

74 hedge funds and large institutions have $487M invested in Zymeworks in 2019 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 24 increasing their positions, 18 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

41% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 17

33% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 18

13% more capital invested

Capital invested by funds: $431M → $487M (+$55.7M)

10% more funds holding

Funds holding: 6774 (+7)

0.18% more ownership

Funds ownership: 50.07%50.26% (+0.18%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

30% less call options, than puts

Call options by funds: $892K | Put options by funds: $1.27M

Holders
74
Holders Change
+7
Holders Change %
+10.45%
% of All Funds
1.62%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
24
Increased
24
Reduced
18
Closed
17
Calls
$892K
Puts
$1.27M
Net Calls
-$375K
Net Calls Change
-$744K
Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$73M +$2.92M +116,690 +4%
GPP
2
Great Point Partners
Connecticut
$61.2M +$35.1M +1,402,703 +132%
PA
3
Perceptive Advisors
New York
$59.2M +$501K +20,000 +0.8%
FCM
4
Farallon Capital Management
California
$42.9M -$626K -24,970 -1%
BBA
5
Baker Bros. Advisors
New York
$42.4M
CCM
6
Camber Capital Management
Massachusetts
$37.2M -$27.6M -1,100,000 -42%
Millennium Management
7
Millennium Management
New York
$34.2M +$3.24M +129,412 +10%
T. Rowe Price Associates
8
T. Rowe Price Associates
Maryland
$16.2M +$8.73M +348,595 +115%
Franklin Resources
9
Franklin Resources
California
$15.8M
PAMU
10
Pictet Asset Management (UK)
United Kingdom
$11.8M +$12M +477,684 New
BNP Paribas Asset Management
11
BNP Paribas Asset Management
France
$10.8M -$505K -20,145 -4%
D.E. Shaw & Co
12
D.E. Shaw & Co
New York
$9.84M +$3.42M +136,528 +52%
Renaissance Technologies
13
Renaissance Technologies
New York
$9.31M +$1.05M +42,107 +13%
Victory Capital Management
14
Victory Capital Management
Texas
$4.86M +$4.91M +195,990 New
Morgan Stanley
15
Morgan Stanley
New York
$4.84M +$2.47M +98,441 +102%
SI
16
Sofinnova Investments
California
$4.67M +$9.55K +381 +0.2%
OM
17
Opaleye Management
Massachusetts
$4.22M
SFM
18
Sphera Funds Management
Israel
$4.22M +$4.26M +170,000 New
MWNA
19
Marshall Wace North America
New York
$3.92M +$3.64M +145,408 +1,169%
Two Sigma Investments
20
Two Sigma Investments
New York
$3.48M -$212K -8,479 -6%
RJA
21
Raymond James & Associates
Florida
$2.79M +$476K +19,007 +20%
TWMP
22
Taylor Wealth Management Partners
Massachusetts
$1.98M -$7.39K -295 -0.4%
DC
23
Diametric Capital
Massachusetts
$1.98M +$2M +79,737 New
OAM
24
Oxford Asset Management
United Kingdom
$1.72M -$1.19M -47,616 -41%
VIA
25
Vident Investment Advisory
Georgia
$1.7M -$64.9K -2,592 -4%

ZYME Hedge Fund Activity: Q3 2019 in Review

74 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Zymeworks (ZYME) for Q3 2019, worth a combined $487M — up 13% from $431M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new ZYME positions and 17 closed out — a net gain of 7 holders — while 24 added to existing stakes and 18 trimmed.

The largest buyer was Great Point Partners, adding an estimated $35.1M. The largest seller was Vivo Capital, exiting entirely with an estimated $32M sold.

  • 74 institutional investors held Zymeworks (ZYME) as of Q3 2019, up from 67 in Q2 2019.
  • Funds reported $487M of Zymeworks stock for Q3 2019, up 13% quarter-over-quarter.
  • 24 funds opened new Zymeworks positions in Q3 2019 and 17 closed out, a net change of +7 holders.
  • The largest Zymeworks buyer in Q3 2019 was Great Point Partners, an estimated $35.1M added.
  • The largest Zymeworks seller in Q3 2019 was Vivo Capital, an estimated $32M sold.

Based on aggregated 13F filings for Q3 2019.